Global Pet Antibiotic Supply, Demand and Key Producers, 2026-2032
The global Pet Antibiotic market size is expected to reach $ 2353 million by 2032, rising at a market growth of 6.1% CAGR during the forecast period (2026-2032).
Pet Antibiotics are antimicrobial pharmaceutical compounds formulated for companion animals such as dogs, cats, and small mammals to prevent, control, and treat bacterial infections affecting skin, respiratory system, urinary tract, gastrointestinal system, and post-surgical wounds, while ensuring safety, dosage precision, and palatability for non-livestock domestic animal use under veterinary supervision.
The Pet Antibiotic industry chain consists of upstream pharmaceutical raw material suppliers producing active pharmaceutical ingredients such as tetracyclines, macrolides, fluoroquinolones, and beta-lactams through fermentation or chemical synthesis along with excipients, flavoring agents, and formulation additives, while midstream manufacturers develop, formulate, and package antibiotics into tablets, injectables, suspensions, and topical products under strict veterinary pharmaceutical quality standards, and downstream distribution channels including veterinary hospitals, clinics, pet pharmacies, online platforms, and pet care providers deliver these products to pet owners and animal shelters for treatment of bacterial infections, post-surgical care, and preventive infection management in companion animals.
Pet Antibiotic projects under construction and planned are primarily driven by expansion in companion animal healthcare infrastructure, increasing pet ownership rates, and rising demand for advanced veterinary pharmaceuticals in North America, Europe, and Asia-Pacific, with investments focusing on new production lines for palatable oral formulations, injectable sterile facilities, and topical antibiotic manufacturing units, alongside digital veterinary pharmacy expansion and online distribution integration, while emerging markets are developing localized veterinary drug production capacity, supported by pet insurance growth, veterinary clinic network expansion, and stricter regulatory compliance frameworks for antimicrobial usage in companion animals and improved drug safety standards.
2025 Global Market Average Gross Profit Margin: 35%.
The pet antibiotic market is a growing niche within the broader veterinary pharmaceutical industry, driven by rising global pet ownership and increasing expenditure on companion animal healthcare. Demand is strongly influenced by urbanization and the humanization of pets, where owners prioritize advanced medical treatment for dogs and cats. Veterinary clinics remain the dominant distribution and prescription channel. North America and Europe are the most mature markets due to high veterinary care penetration and strong regulatory frameworks.
Asia-Pacific is emerging as a fast-growing region supported by expanding pet populations in China, Japan, and South Korea. The market is characterized by high-value, low-volume consumption compared to livestock antibiotics. Oral formulations such as tablets and flavored suspensions dominate due to ease of administration. Skin and respiratory infections represent the most common application areas. Regulatory oversight is stricter than livestock antibiotics, with prescription-only controls in most developed markets. Innovation is focused on palatable formulations to improve compliance in pets. Pharmaceutical companies are increasingly integrating antibiotics into broader companion animal therapeutic portfolios. E-commerce and online veterinary pharmacies are becoming important growth channels. Rising awareness of antimicrobial resistance is gradually shaping prescription behavior among veterinarians. Competitive dynamics are moderately consolidated, with global animal health companies and specialized veterinary drug manufacturers leading the market.
Overall, the market is transitioning toward precision, safety-focused, and pet-friendly antibiotic solutions supported by expanding veterinary healthcare infrastructure.
This report studies the global Pet Antibiotic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pet Antibiotic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pet Antibiotic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pet Antibiotic total market, 2021-2032, (USD Million)
Global Pet Antibiotic total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Pet Antibiotic total market, key domestic companies, and share, (USD Million)
Global Pet Antibiotic revenue by player, revenue and market share 2021-2026, (USD Million)
Global Pet Antibiotic total market by Type, CAGR, 2021-2032, (USD Million)
Global Pet Antibiotic total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pet Antibiotic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, Ceva Sant? Animale, Phibro Animal Health Corporation, Huvepharma, Virbac, Vetoquinol, Pharmgate Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pet Antibiotic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pet Antibiotic Market, By Region:
1. How big is the global Pet Antibiotic market?
2. What is the demand of the global Pet Antibiotic market?
3. What is the year over year growth of the global Pet Antibiotic market?
4. What is the total value of the global Pet Antibiotic market?
5. Who are the Major Players in the global Pet Antibiotic market?
6. What are the growth factors driving the market demand?
Pet Antibiotics are antimicrobial pharmaceutical compounds formulated for companion animals such as dogs, cats, and small mammals to prevent, control, and treat bacterial infections affecting skin, respiratory system, urinary tract, gastrointestinal system, and post-surgical wounds, while ensuring safety, dosage precision, and palatability for non-livestock domestic animal use under veterinary supervision.
The Pet Antibiotic industry chain consists of upstream pharmaceutical raw material suppliers producing active pharmaceutical ingredients such as tetracyclines, macrolides, fluoroquinolones, and beta-lactams through fermentation or chemical synthesis along with excipients, flavoring agents, and formulation additives, while midstream manufacturers develop, formulate, and package antibiotics into tablets, injectables, suspensions, and topical products under strict veterinary pharmaceutical quality standards, and downstream distribution channels including veterinary hospitals, clinics, pet pharmacies, online platforms, and pet care providers deliver these products to pet owners and animal shelters for treatment of bacterial infections, post-surgical care, and preventive infection management in companion animals.
Pet Antibiotic projects under construction and planned are primarily driven by expansion in companion animal healthcare infrastructure, increasing pet ownership rates, and rising demand for advanced veterinary pharmaceuticals in North America, Europe, and Asia-Pacific, with investments focusing on new production lines for palatable oral formulations, injectable sterile facilities, and topical antibiotic manufacturing units, alongside digital veterinary pharmacy expansion and online distribution integration, while emerging markets are developing localized veterinary drug production capacity, supported by pet insurance growth, veterinary clinic network expansion, and stricter regulatory compliance frameworks for antimicrobial usage in companion animals and improved drug safety standards.
2025 Global Market Average Gross Profit Margin: 35%.
The pet antibiotic market is a growing niche within the broader veterinary pharmaceutical industry, driven by rising global pet ownership and increasing expenditure on companion animal healthcare. Demand is strongly influenced by urbanization and the humanization of pets, where owners prioritize advanced medical treatment for dogs and cats. Veterinary clinics remain the dominant distribution and prescription channel. North America and Europe are the most mature markets due to high veterinary care penetration and strong regulatory frameworks.
Asia-Pacific is emerging as a fast-growing region supported by expanding pet populations in China, Japan, and South Korea. The market is characterized by high-value, low-volume consumption compared to livestock antibiotics. Oral formulations such as tablets and flavored suspensions dominate due to ease of administration. Skin and respiratory infections represent the most common application areas. Regulatory oversight is stricter than livestock antibiotics, with prescription-only controls in most developed markets. Innovation is focused on palatable formulations to improve compliance in pets. Pharmaceutical companies are increasingly integrating antibiotics into broader companion animal therapeutic portfolios. E-commerce and online veterinary pharmacies are becoming important growth channels. Rising awareness of antimicrobial resistance is gradually shaping prescription behavior among veterinarians. Competitive dynamics are moderately consolidated, with global animal health companies and specialized veterinary drug manufacturers leading the market.
Overall, the market is transitioning toward precision, safety-focused, and pet-friendly antibiotic solutions supported by expanding veterinary healthcare infrastructure.
This report studies the global Pet Antibiotic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pet Antibiotic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pet Antibiotic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pet Antibiotic total market, 2021-2032, (USD Million)
Global Pet Antibiotic total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Pet Antibiotic total market, key domestic companies, and share, (USD Million)
Global Pet Antibiotic revenue by player, revenue and market share 2021-2026, (USD Million)
Global Pet Antibiotic total market by Type, CAGR, 2021-2032, (USD Million)
Global Pet Antibiotic total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pet Antibiotic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, Ceva Sant? Animale, Phibro Animal Health Corporation, Huvepharma, Virbac, Vetoquinol, Pharmgate Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pet Antibiotic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pet Antibiotic Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tetracyclines
- Macrolides
- Beta-Lactams
- Aminoglycosides
- Others
- Bacteriostatic
- Bactericidal
- Others
- Oral Tablet
- Injectable
- Liquid Suspension
- Topical Ointment
- Dog
- Cat
- Small Mammal
- Exotic
- Zoetis Inc.
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- Merck Animal Health
- Ceva Sant? Animale
- Phibro Animal Health Corporation
- Huvepharma
- Virbac
- Vetoquinol
- Pharmgate Animal Health
- Norbrook Laboratories
- Dechra Pharmaceuticals
- Zydus Animal Health
- Zhejiang Hisun Pharmaceutical Co
- Hunan Weida Technology Co
1. How big is the global Pet Antibiotic market?
2. What is the demand of the global Pet Antibiotic market?
3. What is the year over year growth of the global Pet Antibiotic market?
4. What is the total value of the global Pet Antibiotic market?
5. Who are the Major Players in the global Pet Antibiotic market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pet Antibiotic Introduction
1.2 World Pet Antibiotic Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Pet Antibiotic Total Market by Region (by Headquarter Location)
1.3.1 World Pet Antibiotic Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Pet Antibiotic Revenue (2021-2032)
1.3.3 China Based Company Pet Antibiotic Revenue (2021-2032)
1.3.4 Europe Based Company Pet Antibiotic Revenue (2021-2032)
1.3.5 Japan Based Company Pet Antibiotic Revenue (2021-2032)
1.3.6 South Korea Based Company Pet Antibiotic Revenue (2021-2032)
1.3.7 ASEAN Based Company Pet Antibiotic Revenue (2021-2032)
1.3.8 India Based Company Pet Antibiotic Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pet Antibiotic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Pet Antibiotic Consumption Value (2021-2032)
2.2 World Pet Antibiotic Consumption Value by Region
2.2.1 World Pet Antibiotic Consumption Value by Region (2021-2026)
2.2.2 World Pet Antibiotic Consumption Value Forecast by Region (2027-2032)
2.3 United States Pet Antibiotic Consumption Value (2021-2032)
2.4 China Pet Antibiotic Consumption Value (2021-2032)
2.5 Europe Pet Antibiotic Consumption Value (2021-2032)
2.6 Japan Pet Antibiotic Consumption Value (2021-2032)
2.7 South Korea Pet Antibiotic Consumption Value (2021-2032)
2.8 ASEAN Pet Antibiotic Consumption Value (2021-2032)
2.9 India Pet Antibiotic Consumption Value (2021-2032)
3 WORLD PET ANTIBIOTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Pet Antibiotic Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pet Antibiotic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pet Antibiotic in 2025
3.2.3 Global Concentration Ratios (CR8) for Pet Antibiotic in 2025
3.3 Pet Antibiotic Company Evaluation Quadrant
3.4 Pet Antibiotic Market: Overall Company Footprint Analysis
3.4.1 Pet Antibiotic Market: Region Footprint
3.4.2 Pet Antibiotic Market: Company Product Type Footprint
3.4.3 Pet Antibiotic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pet Antibiotic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pet Antibiotic Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Pet Antibiotic Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Pet Antibiotic Consumption Value Comparison
4.2.1 United States VS China: Pet Antibiotic Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pet Antibiotic Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Pet Antibiotic Companies and Market Share, 2021-2026
4.3.1 United States Based Pet Antibiotic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pet Antibiotic Revenue, (2021-2026)
4.4 China Based Companies Pet Antibiotic Revenue and Market Share, 2021-2026
4.4.1 China Based Pet Antibiotic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pet Antibiotic Revenue, (2021-2026)
4.5 Rest of World Based Pet Antibiotic Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Pet Antibiotic Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Pet Antibiotic Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pet Antibiotic Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tetracyclines
5.2.2 Macrolides
5.2.3 Beta-Lactams
5.2.4 Aminoglycosides
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Pet Antibiotic Market Size by Type (2021-2026)
5.3.2 World Pet Antibiotic Market Size by Type (2027-2032)
5.3.3 World Pet Antibiotic Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MODE OF ACTION TYPE
6.1 World Pet Antibiotic Market Size Overview by Mode Of Action Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Mode Of Action Type
6.2.1 Bacteriostatic
6.2.2 Bactericidal
6.2.3 Others
6.3 Market Segment by Mode Of Action Type
6.3.1 World Pet Antibiotic Market Size by Mode Of Action Type (2021-2026)
6.3.2 World Pet Antibiotic Market Size by Mode Of Action Type (2027-2032)
6.3.3 World Pet Antibiotic Market Size Market Share by Mode Of Action Type (2027-2032)
7 MARKET ANALYSIS BY FORMULATION TYPE
7.1 World Pet Antibiotic Market Size Overview by Formulation Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Formulation Type
7.2.1 Oral Tablet
7.2.2 Injectable
7.2.3 Liquid Suspension
7.2.4 Topical Ointment
7.3 Market Segment by Formulation Type
7.3.1 World Pet Antibiotic Market Size by Formulation Type (2021-2026)
7.3.2 World Pet Antibiotic Market Size by Formulation Type (2027-2032)
7.3.3 World Pet Antibiotic Market Size Market Share by Formulation Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pet Antibiotic Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Dog
8.2.2 Cat
8.2.3 Small Mammal
8.2.4 Exotic
8.3 Market Segment by Application
8.3.1 World Pet Antibiotic Market Size by Application (2021-2026)
8.3.2 World Pet Antibiotic Market Size by Application (2027-2032)
8.3.3 World Pet Antibiotic Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Zoetis Inc.
9.1.1 Zoetis Inc. Details
9.1.2 Zoetis Inc. Major Business
9.1.3 Zoetis Inc. Pet Antibiotic Product and Services
9.1.4 Zoetis Inc. Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Zoetis Inc. Recent Developments/Updates
9.1.6 Zoetis Inc. Competitive Strengths & Weaknesses
9.2 Elanco Animal Health
9.2.1 Elanco Animal Health Details
9.2.2 Elanco Animal Health Major Business
9.2.3 Elanco Animal Health Pet Antibiotic Product and Services
9.2.4 Elanco Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Elanco Animal Health Recent Developments/Updates
9.2.6 Elanco Animal Health Competitive Strengths & Weaknesses
9.3 Boehringer Ingelheim Animal Health
9.3.1 Boehringer Ingelheim Animal Health Details
9.3.2 Boehringer Ingelheim Animal Health Major Business
9.3.3 Boehringer Ingelheim Animal Health Pet Antibiotic Product and Services
9.3.4 Boehringer Ingelheim Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
9.3.6 Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
9.4 Merck Animal Health
9.4.1 Merck Animal Health Details
9.4.2 Merck Animal Health Major Business
9.4.3 Merck Animal Health Pet Antibiotic Product and Services
9.4.4 Merck Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck Animal Health Recent Developments/Updates
9.4.6 Merck Animal Health Competitive Strengths & Weaknesses
9.5 Ceva Sant? Animale
9.5.1 Ceva Sant? Animale Details
9.5.2 Ceva Sant? Animale Major Business
9.5.3 Ceva Sant? Animale Pet Antibiotic Product and Services
9.5.4 Ceva Sant? Animale Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Ceva Sant? Animale Recent Developments/Updates
9.5.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
9.6 Phibro Animal Health Corporation
9.6.1 Phibro Animal Health Corporation Details
9.6.2 Phibro Animal Health Corporation Major Business
9.6.3 Phibro Animal Health Corporation Pet Antibiotic Product and Services
9.6.4 Phibro Animal Health Corporation Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Phibro Animal Health Corporation Recent Developments/Updates
9.6.6 Phibro Animal Health Corporation Competitive Strengths & Weaknesses
9.7 Huvepharma
9.7.1 Huvepharma Details
9.7.2 Huvepharma Major Business
9.7.3 Huvepharma Pet Antibiotic Product and Services
9.7.4 Huvepharma Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Huvepharma Recent Developments/Updates
9.7.6 Huvepharma Competitive Strengths & Weaknesses
9.8 Virbac
9.8.1 Virbac Details
9.8.2 Virbac Major Business
9.8.3 Virbac Pet Antibiotic Product and Services
9.8.4 Virbac Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Virbac Recent Developments/Updates
9.8.6 Virbac Competitive Strengths & Weaknesses
9.9 Vetoquinol
9.9.1 Vetoquinol Details
9.9.2 Vetoquinol Major Business
9.9.3 Vetoquinol Pet Antibiotic Product and Services
9.9.4 Vetoquinol Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Vetoquinol Recent Developments/Updates
9.9.6 Vetoquinol Competitive Strengths & Weaknesses
9.10 Pharmgate Animal Health
9.10.1 Pharmgate Animal Health Details
9.10.2 Pharmgate Animal Health Major Business
9.10.3 Pharmgate Animal Health Pet Antibiotic Product and Services
9.10.4 Pharmgate Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Pharmgate Animal Health Recent Developments/Updates
9.10.6 Pharmgate Animal Health Competitive Strengths & Weaknesses
9.11 Norbrook Laboratories
9.11.1 Norbrook Laboratories Details
9.11.2 Norbrook Laboratories Major Business
9.11.3 Norbrook Laboratories Pet Antibiotic Product and Services
9.11.4 Norbrook Laboratories Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Norbrook Laboratories Recent Developments/Updates
9.11.6 Norbrook Laboratories Competitive Strengths & Weaknesses
9.12 Dechra Pharmaceuticals
9.12.1 Dechra Pharmaceuticals Details
9.12.2 Dechra Pharmaceuticals Major Business
9.12.3 Dechra Pharmaceuticals Pet Antibiotic Product and Services
9.12.4 Dechra Pharmaceuticals Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Dechra Pharmaceuticals Recent Developments/Updates
9.12.6 Dechra Pharmaceuticals Competitive Strengths & Weaknesses
9.13 Zydus Animal Health
9.13.1 Zydus Animal Health Details
9.13.2 Zydus Animal Health Major Business
9.13.3 Zydus Animal Health Pet Antibiotic Product and Services
9.13.4 Zydus Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Zydus Animal Health Recent Developments/Updates
9.13.6 Zydus Animal Health Competitive Strengths & Weaknesses
9.14 Zhejiang Hisun Pharmaceutical Co
9.14.1 Zhejiang Hisun Pharmaceutical Co Details
9.14.2 Zhejiang Hisun Pharmaceutical Co Major Business
9.14.3 Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Product and Services
9.14.4 Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Zhejiang Hisun Pharmaceutical Co Recent Developments/Updates
9.14.6 Zhejiang Hisun Pharmaceutical Co Competitive Strengths & Weaknesses
9.15 Hunan Weida Technology Co
9.15.1 Hunan Weida Technology Co Details
9.15.2 Hunan Weida Technology Co Major Business
9.15.3 Hunan Weida Technology Co Pet Antibiotic Product and Services
9.15.4 Hunan Weida Technology Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Hunan Weida Technology Co Recent Developments/Updates
9.15.6 Hunan Weida Technology Co Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pet Antibiotic Industry Chain
10.2 Pet Antibiotic Upstream Analysis
10.3 Pet Antibiotic Midstream Analysis
10.4 Pet Antibiotic Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Pet Antibiotic Introduction
1.2 World Pet Antibiotic Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Pet Antibiotic Total Market by Region (by Headquarter Location)
1.3.1 World Pet Antibiotic Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Pet Antibiotic Revenue (2021-2032)
1.3.3 China Based Company Pet Antibiotic Revenue (2021-2032)
1.3.4 Europe Based Company Pet Antibiotic Revenue (2021-2032)
1.3.5 Japan Based Company Pet Antibiotic Revenue (2021-2032)
1.3.6 South Korea Based Company Pet Antibiotic Revenue (2021-2032)
1.3.7 ASEAN Based Company Pet Antibiotic Revenue (2021-2032)
1.3.8 India Based Company Pet Antibiotic Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pet Antibiotic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Pet Antibiotic Consumption Value (2021-2032)
2.2 World Pet Antibiotic Consumption Value by Region
2.2.1 World Pet Antibiotic Consumption Value by Region (2021-2026)
2.2.2 World Pet Antibiotic Consumption Value Forecast by Region (2027-2032)
2.3 United States Pet Antibiotic Consumption Value (2021-2032)
2.4 China Pet Antibiotic Consumption Value (2021-2032)
2.5 Europe Pet Antibiotic Consumption Value (2021-2032)
2.6 Japan Pet Antibiotic Consumption Value (2021-2032)
2.7 South Korea Pet Antibiotic Consumption Value (2021-2032)
2.8 ASEAN Pet Antibiotic Consumption Value (2021-2032)
2.9 India Pet Antibiotic Consumption Value (2021-2032)
3 WORLD PET ANTIBIOTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Pet Antibiotic Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pet Antibiotic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pet Antibiotic in 2025
3.2.3 Global Concentration Ratios (CR8) for Pet Antibiotic in 2025
3.3 Pet Antibiotic Company Evaluation Quadrant
3.4 Pet Antibiotic Market: Overall Company Footprint Analysis
3.4.1 Pet Antibiotic Market: Region Footprint
3.4.2 Pet Antibiotic Market: Company Product Type Footprint
3.4.3 Pet Antibiotic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pet Antibiotic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pet Antibiotic Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Pet Antibiotic Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Pet Antibiotic Consumption Value Comparison
4.2.1 United States VS China: Pet Antibiotic Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pet Antibiotic Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Pet Antibiotic Companies and Market Share, 2021-2026
4.3.1 United States Based Pet Antibiotic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pet Antibiotic Revenue, (2021-2026)
4.4 China Based Companies Pet Antibiotic Revenue and Market Share, 2021-2026
4.4.1 China Based Pet Antibiotic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pet Antibiotic Revenue, (2021-2026)
4.5 Rest of World Based Pet Antibiotic Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Pet Antibiotic Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Pet Antibiotic Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pet Antibiotic Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tetracyclines
5.2.2 Macrolides
5.2.3 Beta-Lactams
5.2.4 Aminoglycosides
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Pet Antibiotic Market Size by Type (2021-2026)
5.3.2 World Pet Antibiotic Market Size by Type (2027-2032)
5.3.3 World Pet Antibiotic Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MODE OF ACTION TYPE
6.1 World Pet Antibiotic Market Size Overview by Mode Of Action Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Mode Of Action Type
6.2.1 Bacteriostatic
6.2.2 Bactericidal
6.2.3 Others
6.3 Market Segment by Mode Of Action Type
6.3.1 World Pet Antibiotic Market Size by Mode Of Action Type (2021-2026)
6.3.2 World Pet Antibiotic Market Size by Mode Of Action Type (2027-2032)
6.3.3 World Pet Antibiotic Market Size Market Share by Mode Of Action Type (2027-2032)
7 MARKET ANALYSIS BY FORMULATION TYPE
7.1 World Pet Antibiotic Market Size Overview by Formulation Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Formulation Type
7.2.1 Oral Tablet
7.2.2 Injectable
7.2.3 Liquid Suspension
7.2.4 Topical Ointment
7.3 Market Segment by Formulation Type
7.3.1 World Pet Antibiotic Market Size by Formulation Type (2021-2026)
7.3.2 World Pet Antibiotic Market Size by Formulation Type (2027-2032)
7.3.3 World Pet Antibiotic Market Size Market Share by Formulation Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pet Antibiotic Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Dog
8.2.2 Cat
8.2.3 Small Mammal
8.2.4 Exotic
8.3 Market Segment by Application
8.3.1 World Pet Antibiotic Market Size by Application (2021-2026)
8.3.2 World Pet Antibiotic Market Size by Application (2027-2032)
8.3.3 World Pet Antibiotic Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Zoetis Inc.
9.1.1 Zoetis Inc. Details
9.1.2 Zoetis Inc. Major Business
9.1.3 Zoetis Inc. Pet Antibiotic Product and Services
9.1.4 Zoetis Inc. Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Zoetis Inc. Recent Developments/Updates
9.1.6 Zoetis Inc. Competitive Strengths & Weaknesses
9.2 Elanco Animal Health
9.2.1 Elanco Animal Health Details
9.2.2 Elanco Animal Health Major Business
9.2.3 Elanco Animal Health Pet Antibiotic Product and Services
9.2.4 Elanco Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Elanco Animal Health Recent Developments/Updates
9.2.6 Elanco Animal Health Competitive Strengths & Weaknesses
9.3 Boehringer Ingelheim Animal Health
9.3.1 Boehringer Ingelheim Animal Health Details
9.3.2 Boehringer Ingelheim Animal Health Major Business
9.3.3 Boehringer Ingelheim Animal Health Pet Antibiotic Product and Services
9.3.4 Boehringer Ingelheim Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
9.3.6 Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
9.4 Merck Animal Health
9.4.1 Merck Animal Health Details
9.4.2 Merck Animal Health Major Business
9.4.3 Merck Animal Health Pet Antibiotic Product and Services
9.4.4 Merck Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck Animal Health Recent Developments/Updates
9.4.6 Merck Animal Health Competitive Strengths & Weaknesses
9.5 Ceva Sant? Animale
9.5.1 Ceva Sant? Animale Details
9.5.2 Ceva Sant? Animale Major Business
9.5.3 Ceva Sant? Animale Pet Antibiotic Product and Services
9.5.4 Ceva Sant? Animale Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Ceva Sant? Animale Recent Developments/Updates
9.5.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
9.6 Phibro Animal Health Corporation
9.6.1 Phibro Animal Health Corporation Details
9.6.2 Phibro Animal Health Corporation Major Business
9.6.3 Phibro Animal Health Corporation Pet Antibiotic Product and Services
9.6.4 Phibro Animal Health Corporation Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Phibro Animal Health Corporation Recent Developments/Updates
9.6.6 Phibro Animal Health Corporation Competitive Strengths & Weaknesses
9.7 Huvepharma
9.7.1 Huvepharma Details
9.7.2 Huvepharma Major Business
9.7.3 Huvepharma Pet Antibiotic Product and Services
9.7.4 Huvepharma Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Huvepharma Recent Developments/Updates
9.7.6 Huvepharma Competitive Strengths & Weaknesses
9.8 Virbac
9.8.1 Virbac Details
9.8.2 Virbac Major Business
9.8.3 Virbac Pet Antibiotic Product and Services
9.8.4 Virbac Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Virbac Recent Developments/Updates
9.8.6 Virbac Competitive Strengths & Weaknesses
9.9 Vetoquinol
9.9.1 Vetoquinol Details
9.9.2 Vetoquinol Major Business
9.9.3 Vetoquinol Pet Antibiotic Product and Services
9.9.4 Vetoquinol Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Vetoquinol Recent Developments/Updates
9.9.6 Vetoquinol Competitive Strengths & Weaknesses
9.10 Pharmgate Animal Health
9.10.1 Pharmgate Animal Health Details
9.10.2 Pharmgate Animal Health Major Business
9.10.3 Pharmgate Animal Health Pet Antibiotic Product and Services
9.10.4 Pharmgate Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Pharmgate Animal Health Recent Developments/Updates
9.10.6 Pharmgate Animal Health Competitive Strengths & Weaknesses
9.11 Norbrook Laboratories
9.11.1 Norbrook Laboratories Details
9.11.2 Norbrook Laboratories Major Business
9.11.3 Norbrook Laboratories Pet Antibiotic Product and Services
9.11.4 Norbrook Laboratories Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Norbrook Laboratories Recent Developments/Updates
9.11.6 Norbrook Laboratories Competitive Strengths & Weaknesses
9.12 Dechra Pharmaceuticals
9.12.1 Dechra Pharmaceuticals Details
9.12.2 Dechra Pharmaceuticals Major Business
9.12.3 Dechra Pharmaceuticals Pet Antibiotic Product and Services
9.12.4 Dechra Pharmaceuticals Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Dechra Pharmaceuticals Recent Developments/Updates
9.12.6 Dechra Pharmaceuticals Competitive Strengths & Weaknesses
9.13 Zydus Animal Health
9.13.1 Zydus Animal Health Details
9.13.2 Zydus Animal Health Major Business
9.13.3 Zydus Animal Health Pet Antibiotic Product and Services
9.13.4 Zydus Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Zydus Animal Health Recent Developments/Updates
9.13.6 Zydus Animal Health Competitive Strengths & Weaknesses
9.14 Zhejiang Hisun Pharmaceutical Co
9.14.1 Zhejiang Hisun Pharmaceutical Co Details
9.14.2 Zhejiang Hisun Pharmaceutical Co Major Business
9.14.3 Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Product and Services
9.14.4 Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Zhejiang Hisun Pharmaceutical Co Recent Developments/Updates
9.14.6 Zhejiang Hisun Pharmaceutical Co Competitive Strengths & Weaknesses
9.15 Hunan Weida Technology Co
9.15.1 Hunan Weida Technology Co Details
9.15.2 Hunan Weida Technology Co Major Business
9.15.3 Hunan Weida Technology Co Pet Antibiotic Product and Services
9.15.4 Hunan Weida Technology Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Hunan Weida Technology Co Recent Developments/Updates
9.15.6 Hunan Weida Technology Co Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pet Antibiotic Industry Chain
10.2 Pet Antibiotic Upstream Analysis
10.3 Pet Antibiotic Midstream Analysis
10.4 Pet Antibiotic Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Pet Antibiotic Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Pet Antibiotic Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Pet Antibiotic Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Pet Antibiotic Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Pet Antibiotic Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pet Antibiotic Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Pet Antibiotic Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Pet Antibiotic Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Pet Antibiotic Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Pet Antibiotic Players in 2025
Table 12. World Pet Antibiotic Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Pet Antibiotic Company Evaluation Quadrant
Table 14. Head Office of Key Pet Antibiotic Players
Table 15. Pet Antibiotic Market: Company Product Type Footprint
Table 16. Pet Antibiotic Market: Company Product Application Footprint
Table 17. Pet Antibiotic Mergers & Acquisitions Activity
Table 18. United States VS China Pet Antibiotic Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Pet Antibiotic Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Pet Antibiotic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pet Antibiotic Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Pet Antibiotic Revenue Market Share (2021-2026)
Table 23. China Based Pet Antibiotic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pet Antibiotic Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Pet Antibiotic Revenue Market Share (2021-2026)
Table 26. Rest of World Based Pet Antibiotic Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Pet Antibiotic Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Pet Antibiotic Revenue Market Share (2021-2026)
Table 29. World Pet Antibiotic Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Pet Antibiotic Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Pet Antibiotic Market Size by Type (2027-2032) & (USD Million)
Table 32. World Pet Antibiotic Market Size by Mode Of Action Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Pet Antibiotic Market Size Value by Mode Of Action Type (2021-2026) & (USD Million)
Table 34. World Pet Antibiotic Market Size by Mode Of Action Type (2027-2032) & (USD Million)
Table 35. World Pet Antibiotic Market Size by Formulation Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Pet Antibiotic Market Size Value by Formulation Type (2021-2026) & (USD Million)
Table 37. World Pet Antibiotic Market Size by Formulation Type (2027-2032) & (USD Million)
Table 38. World Pet Antibiotic Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Pet Antibiotic Market Size by Application (2021-2026) & (USD Million)
Table 40. World Pet Antibiotic Market Size by Application (2027-2032) & (USD Million)
Table 41. Zoetis Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Zoetis Inc. Major Business
Table 43. Zoetis Inc. Pet Antibiotic Product and Services
Table 44. Zoetis Inc. Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Zoetis Inc. Recent Developments/Updates
Table 46. Zoetis Inc. Competitive Strengths & Weaknesses
Table 47. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 48. Elanco Animal Health Major Business
Table 49. Elanco Animal Health Pet Antibiotic Product and Services
Table 50. Elanco Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Elanco Animal Health Recent Developments/Updates
Table 52. Elanco Animal Health Competitive Strengths & Weaknesses
Table 53. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 54. Boehringer Ingelheim Animal Health Major Business
Table 55. Boehringer Ingelheim Animal Health Pet Antibiotic Product and Services
Table 56. Boehringer Ingelheim Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 58. Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
Table 59. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 60. Merck Animal Health Major Business
Table 61. Merck Animal Health Pet Antibiotic Product and Services
Table 62. Merck Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck Animal Health Recent Developments/Updates
Table 64. Merck Animal Health Competitive Strengths & Weaknesses
Table 65. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 66. Ceva Sant? Animale Major Business
Table 67. Ceva Sant? Animale Pet Antibiotic Product and Services
Table 68. Ceva Sant? Animale Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Ceva Sant? Animale Recent Developments/Updates
Table 70. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 71. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 72. Phibro Animal Health Corporation Major Business
Table 73. Phibro Animal Health Corporation Pet Antibiotic Product and Services
Table 74. Phibro Animal Health Corporation Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Phibro Animal Health Corporation Recent Developments/Updates
Table 76. Phibro Animal Health Corporation Competitive Strengths & Weaknesses
Table 77. Huvepharma Basic Information, Manufacturing Base and Competitors
Table 78. Huvepharma Major Business
Table 79. Huvepharma Pet Antibiotic Product and Services
Table 80. Huvepharma Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Huvepharma Recent Developments/Updates
Table 82. Huvepharma Competitive Strengths & Weaknesses
Table 83. Virbac Basic Information, Manufacturing Base and Competitors
Table 84. Virbac Major Business
Table 85. Virbac Pet Antibiotic Product and Services
Table 86. Virbac Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Virbac Recent Developments/Updates
Table 88. Virbac Competitive Strengths & Weaknesses
Table 89. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 90. Vetoquinol Major Business
Table 91. Vetoquinol Pet Antibiotic Product and Services
Table 92. Vetoquinol Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Vetoquinol Recent Developments/Updates
Table 94. Vetoquinol Competitive Strengths & Weaknesses
Table 95. Pharmgate Animal Health Basic Information, Manufacturing Base and Competitors
Table 96. Pharmgate Animal Health Major Business
Table 97. Pharmgate Animal Health Pet Antibiotic Product and Services
Table 98. Pharmgate Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Pharmgate Animal Health Recent Developments/Updates
Table 100. Pharmgate Animal Health Competitive Strengths & Weaknesses
Table 101. Norbrook Laboratories Basic Information, Manufacturing Base and Competitors
Table 102. Norbrook Laboratories Major Business
Table 103. Norbrook Laboratories Pet Antibiotic Product and Services
Table 104. Norbrook Laboratories Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Norbrook Laboratories Recent Developments/Updates
Table 106. Norbrook Laboratories Competitive Strengths & Weaknesses
Table 107. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 108. Dechra Pharmaceuticals Major Business
Table 109. Dechra Pharmaceuticals Pet Antibiotic Product and Services
Table 110. Dechra Pharmaceuticals Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Dechra Pharmaceuticals Recent Developments/Updates
Table 112. Dechra Pharmaceuticals Competitive Strengths & Weaknesses
Table 113. Zydus Animal Health Basic Information, Manufacturing Base and Competitors
Table 114. Zydus Animal Health Major Business
Table 115. Zydus Animal Health Pet Antibiotic Product and Services
Table 116. Zydus Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Zydus Animal Health Recent Developments/Updates
Table 118. Zydus Animal Health Competitive Strengths & Weaknesses
Table 119. Zhejiang Hisun Pharmaceutical Co Basic Information, Manufacturing Base and Competitors
Table 120. Zhejiang Hisun Pharmaceutical Co Major Business
Table 121. Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Product and Services
Table 122. Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Zhejiang Hisun Pharmaceutical Co Recent Developments/Updates
Table 124. Zhejiang Hisun Pharmaceutical Co Competitive Strengths & Weaknesses
Table 125. Hunan Weida Technology Co Basic Information, Manufacturing Base and Competitors
Table 126. Hunan Weida Technology Co Major Business
Table 127. Hunan Weida Technology Co Pet Antibiotic Product and Services
Table 128. Hunan Weida Technology Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Hunan Weida Technology Co Recent Developments/Updates
Table 130. Hunan Weida Technology Co Competitive Strengths & Weaknesses
Table 131. Global Key Players of Pet Antibiotic Upstream (Raw Materials)
Table 132. Global Pet Antibiotic Typical Customers
Table 1. World Pet Antibiotic Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Pet Antibiotic Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Pet Antibiotic Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Pet Antibiotic Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Pet Antibiotic Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pet Antibiotic Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Pet Antibiotic Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Pet Antibiotic Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Pet Antibiotic Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Pet Antibiotic Players in 2025
Table 12. World Pet Antibiotic Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Pet Antibiotic Company Evaluation Quadrant
Table 14. Head Office of Key Pet Antibiotic Players
Table 15. Pet Antibiotic Market: Company Product Type Footprint
Table 16. Pet Antibiotic Market: Company Product Application Footprint
Table 17. Pet Antibiotic Mergers & Acquisitions Activity
Table 18. United States VS China Pet Antibiotic Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Pet Antibiotic Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Pet Antibiotic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pet Antibiotic Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Pet Antibiotic Revenue Market Share (2021-2026)
Table 23. China Based Pet Antibiotic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pet Antibiotic Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Pet Antibiotic Revenue Market Share (2021-2026)
Table 26. Rest of World Based Pet Antibiotic Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Pet Antibiotic Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Pet Antibiotic Revenue Market Share (2021-2026)
Table 29. World Pet Antibiotic Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Pet Antibiotic Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Pet Antibiotic Market Size by Type (2027-2032) & (USD Million)
Table 32. World Pet Antibiotic Market Size by Mode Of Action Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Pet Antibiotic Market Size Value by Mode Of Action Type (2021-2026) & (USD Million)
Table 34. World Pet Antibiotic Market Size by Mode Of Action Type (2027-2032) & (USD Million)
Table 35. World Pet Antibiotic Market Size by Formulation Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Pet Antibiotic Market Size Value by Formulation Type (2021-2026) & (USD Million)
Table 37. World Pet Antibiotic Market Size by Formulation Type (2027-2032) & (USD Million)
Table 38. World Pet Antibiotic Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Pet Antibiotic Market Size by Application (2021-2026) & (USD Million)
Table 40. World Pet Antibiotic Market Size by Application (2027-2032) & (USD Million)
Table 41. Zoetis Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Zoetis Inc. Major Business
Table 43. Zoetis Inc. Pet Antibiotic Product and Services
Table 44. Zoetis Inc. Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Zoetis Inc. Recent Developments/Updates
Table 46. Zoetis Inc. Competitive Strengths & Weaknesses
Table 47. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 48. Elanco Animal Health Major Business
Table 49. Elanco Animal Health Pet Antibiotic Product and Services
Table 50. Elanco Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Elanco Animal Health Recent Developments/Updates
Table 52. Elanco Animal Health Competitive Strengths & Weaknesses
Table 53. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 54. Boehringer Ingelheim Animal Health Major Business
Table 55. Boehringer Ingelheim Animal Health Pet Antibiotic Product and Services
Table 56. Boehringer Ingelheim Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 58. Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
Table 59. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 60. Merck Animal Health Major Business
Table 61. Merck Animal Health Pet Antibiotic Product and Services
Table 62. Merck Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck Animal Health Recent Developments/Updates
Table 64. Merck Animal Health Competitive Strengths & Weaknesses
Table 65. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 66. Ceva Sant? Animale Major Business
Table 67. Ceva Sant? Animale Pet Antibiotic Product and Services
Table 68. Ceva Sant? Animale Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Ceva Sant? Animale Recent Developments/Updates
Table 70. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 71. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 72. Phibro Animal Health Corporation Major Business
Table 73. Phibro Animal Health Corporation Pet Antibiotic Product and Services
Table 74. Phibro Animal Health Corporation Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Phibro Animal Health Corporation Recent Developments/Updates
Table 76. Phibro Animal Health Corporation Competitive Strengths & Weaknesses
Table 77. Huvepharma Basic Information, Manufacturing Base and Competitors
Table 78. Huvepharma Major Business
Table 79. Huvepharma Pet Antibiotic Product and Services
Table 80. Huvepharma Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Huvepharma Recent Developments/Updates
Table 82. Huvepharma Competitive Strengths & Weaknesses
Table 83. Virbac Basic Information, Manufacturing Base and Competitors
Table 84. Virbac Major Business
Table 85. Virbac Pet Antibiotic Product and Services
Table 86. Virbac Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Virbac Recent Developments/Updates
Table 88. Virbac Competitive Strengths & Weaknesses
Table 89. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 90. Vetoquinol Major Business
Table 91. Vetoquinol Pet Antibiotic Product and Services
Table 92. Vetoquinol Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Vetoquinol Recent Developments/Updates
Table 94. Vetoquinol Competitive Strengths & Weaknesses
Table 95. Pharmgate Animal Health Basic Information, Manufacturing Base and Competitors
Table 96. Pharmgate Animal Health Major Business
Table 97. Pharmgate Animal Health Pet Antibiotic Product and Services
Table 98. Pharmgate Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Pharmgate Animal Health Recent Developments/Updates
Table 100. Pharmgate Animal Health Competitive Strengths & Weaknesses
Table 101. Norbrook Laboratories Basic Information, Manufacturing Base and Competitors
Table 102. Norbrook Laboratories Major Business
Table 103. Norbrook Laboratories Pet Antibiotic Product and Services
Table 104. Norbrook Laboratories Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Norbrook Laboratories Recent Developments/Updates
Table 106. Norbrook Laboratories Competitive Strengths & Weaknesses
Table 107. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 108. Dechra Pharmaceuticals Major Business
Table 109. Dechra Pharmaceuticals Pet Antibiotic Product and Services
Table 110. Dechra Pharmaceuticals Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Dechra Pharmaceuticals Recent Developments/Updates
Table 112. Dechra Pharmaceuticals Competitive Strengths & Weaknesses
Table 113. Zydus Animal Health Basic Information, Manufacturing Base and Competitors
Table 114. Zydus Animal Health Major Business
Table 115. Zydus Animal Health Pet Antibiotic Product and Services
Table 116. Zydus Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Zydus Animal Health Recent Developments/Updates
Table 118. Zydus Animal Health Competitive Strengths & Weaknesses
Table 119. Zhejiang Hisun Pharmaceutical Co Basic Information, Manufacturing Base and Competitors
Table 120. Zhejiang Hisun Pharmaceutical Co Major Business
Table 121. Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Product and Services
Table 122. Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Zhejiang Hisun Pharmaceutical Co Recent Developments/Updates
Table 124. Zhejiang Hisun Pharmaceutical Co Competitive Strengths & Weaknesses
Table 125. Hunan Weida Technology Co Basic Information, Manufacturing Base and Competitors
Table 126. Hunan Weida Technology Co Major Business
Table 127. Hunan Weida Technology Co Pet Antibiotic Product and Services
Table 128. Hunan Weida Technology Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Hunan Weida Technology Co Recent Developments/Updates
Table 130. Hunan Weida Technology Co Competitive Strengths & Weaknesses
Table 131. Global Key Players of Pet Antibiotic Upstream (Raw Materials)
Table 132. Global Pet Antibiotic Typical Customers
LIST OF FIGURES
Figure 1. Pet Antibiotic Picture
Figure 2. World Pet Antibiotic Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pet Antibiotic Total Revenue (2021-2032) & (USD Million)
Figure 4. World Pet Antibiotic Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Pet Antibiotic Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 13. Pet Antibiotic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 16. World Pet Antibiotic Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 18. China Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 23. India Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Pet Antibiotic by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pet Antibiotic Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pet Antibiotic Markets in 2025
Figure 27. United States VS China: Pet Antibiotic Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pet Antibiotic Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Pet Antibiotic Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Pet Antibiotic Market Size Market Share by Type in 2025
Figure 31. Tetracyclines
Figure 32. Macrolides
Figure 33. Beta-Lactams
Figure 34. Aminoglycosides
Figure 35. Others
Figure 36. World Pet Antibiotic Market Size Market Share by Type (2021-2032)
Figure 37. World Pet Antibiotic Market Size by Mode Of Action Type, (USD Million), 2021 & 2025 & 2032
Figure 38. World Pet Antibiotic Market Size Market Share by Mode Of Action Type in 2025
Figure 39. Bacteriostatic
Figure 40. Bactericidal
Figure 41. Others
Figure 42. World Pet Antibiotic Market Size Market Share by Mode Of Action Type (2021-2032)
Figure 43. World Pet Antibiotic Market Size by Formulation Type, (USD Million), 2021 & 2025 & 2032
Figure 44. World Pet Antibiotic Market Size Market Share by Formulation Type in 2025
Figure 45. OralTablet
Figure 46. Injectable
Figure 47. Liquid Suspension
Figure 48. Topical Ointment
Figure 49. World Pet Antibiotic Market Size Market Share by Formulation Type (2021-2032)
Figure 50. World Pet Antibiotic Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Pet Antibiotic Market Size Market Share by Application in 2025
Figure 52. Dog
Figure 53. Cat
Figure 54. Small Mammal
Figure 55. Exotic
Figure 56. World Pet Antibiotic Market Size Market Share by Application (2021-2032)
Figure 57. Pet Antibiotic Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Pet Antibiotic Picture
Figure 2. World Pet Antibiotic Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pet Antibiotic Total Revenue (2021-2032) & (USD Million)
Figure 4. World Pet Antibiotic Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Pet Antibiotic Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Pet Antibiotic Revenue (2021-2032) & (USD Million)
Figure 13. Pet Antibiotic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 16. World Pet Antibiotic Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 18. China Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 23. India Pet Antibiotic Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Pet Antibiotic by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pet Antibiotic Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pet Antibiotic Markets in 2025
Figure 27. United States VS China: Pet Antibiotic Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pet Antibiotic Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Pet Antibiotic Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Pet Antibiotic Market Size Market Share by Type in 2025
Figure 31. Tetracyclines
Figure 32. Macrolides
Figure 33. Beta-Lactams
Figure 34. Aminoglycosides
Figure 35. Others
Figure 36. World Pet Antibiotic Market Size Market Share by Type (2021-2032)
Figure 37. World Pet Antibiotic Market Size by Mode Of Action Type, (USD Million), 2021 & 2025 & 2032
Figure 38. World Pet Antibiotic Market Size Market Share by Mode Of Action Type in 2025
Figure 39. Bacteriostatic
Figure 40. Bactericidal
Figure 41. Others
Figure 42. World Pet Antibiotic Market Size Market Share by Mode Of Action Type (2021-2032)
Figure 43. World Pet Antibiotic Market Size by Formulation Type, (USD Million), 2021 & 2025 & 2032
Figure 44. World Pet Antibiotic Market Size Market Share by Formulation Type in 2025
Figure 45. OralTablet
Figure 46. Injectable
Figure 47. Liquid Suspension
Figure 48. Topical Ointment
Figure 49. World Pet Antibiotic Market Size Market Share by Formulation Type (2021-2032)
Figure 50. World Pet Antibiotic Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Pet Antibiotic Market Size Market Share by Application in 2025
Figure 52. Dog
Figure 53. Cat
Figure 54. Small Mammal
Figure 55. Exotic
Figure 56. World Pet Antibiotic Market Size Market Share by Application (2021-2032)
Figure 57. Pet Antibiotic Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
